Isu Abxis ranked among the top searched stocks for 3 days in the past month.


As of 11:31 AM on the 15th, Isu Abxis is trading at 14,150 KRW, up 29.82% from the previous day. This represents a 102.43% increase compared to January 18. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.

Today, foreigners have net purchased 724,500 shares of Isu Abxis, while institutions have net sold 200,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 146,104 shares, while foreigners and institutions have net purchased 114,525 shares and 72,480 shares, respectively.


On February 10, Isu Abxis was a market issue with the headline "Strong performance on news of Russian COVID vaccine contract production."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing